Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry
Lindsay A. Schelling(Indiana University School of Medicine), Liang Cheng(University of North Carolina at Chapel Hill), Robert E. Emerson(Indiana University – Purdue University Indianapolis), Gregory T. MacLennan(Case Western Reserve University), Jiaoti Huang(Duke University), Antonio López-Beltrán(Cordoba University), Muhammad T. Idrees(Indiana University School of Medicine), Adeboye O. Osunkoya(Emory University), Rodolfo Montironi(Marche Polytechnic University), Éva Compérat(Vienna General Hospital), Ming‐Sheng Wang(Indiana University School of Medicine), Yan-Gao Man, Jorge L. Yao(University of Rochester), Lee Ann Baldridge(Indiana University School of Medicine), Shaobo Zhang(Indiana University – Purdue University Indianapolis), Sean R. Williamson(Wayne State University)
Cited by 50
Related Papers
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
EAU Guidelines on Penile Cancer: 2014 Update
|European Urology|2014|594
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289